http://142-54-23-223.fusionmedialtd.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 16 Jul 2026 06:15:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://142-54-23-223.fusionmedialtd.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++IMMUNIC%2C+INC.++++++++++++++++++++++++++Filed+by%3A+Aberdeen+Group+plc/26776127.html si-local-file:///var/storage/secattach/20260716/26776127.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++IMMUNIC%2C+INC.++++++++++++++++++++++++++Filed+by%3A+Aberdeen+Group+plc/26776127.html Thu, 16 Jul 2026 06:15:00 -0400 IMUX O.02321652 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++IMMUNIC%2C+INC.++++++++++++++++++++++++++Filed+by%3A+Aberdeen+Group+plc/26776127.html si-local-file:///var/storage/secattach/20260716/26776127.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++IMMUNIC%2C+INC.++++++++++++++++++++++++++Filed+by%3A+Aberdeen+Group+plc/26776127.html Thu, 16 Jul 2026 06:15:00 -0400 IMUX O.02321652 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+14/26765149.html si-local-file:///var/storage/secattach/20260714/26765149.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+14/26765149.html Tue, 14 Jul 2026 08:01:00 -0400 IMUX O.02321652 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+14/26765149.html si-local-file:///var/storage/secattach/20260714/26765149.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+14/26765149.html Tue, 14 Jul 2026 08:01:00 -0400 IMUX O.02321652 http://www.streetinsider.com/Press+Releases/Immunic+to+Participate+in+Investor+Conferences+in+July/26749711.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 9, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4727649-1&amp;h=3646705886&amp;u=https%3A%2F%2Fimux.com%2F&amp;a=Immunic%2C+Inc." target="_blank" rel="nofollow"><b><span value="NASDAQ-NMS:IMUX" idsrc="xmltag.org" >Immunic</span></b><b>, Inc.</b></a><b> (Nasdaq: IMUX)</b>, a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following investor conferences in July:</p><ul type="disc"><li><chron>July 14-15</chron>: <b><span>Leerink Partners Therapeutics Forum</span>.</b> Erik Lundgren, Chief Executive Officer, <person>Jason Tardio</person>, President and Chief Operating Officer, <person>Michael A. Panzara</person>, M.D., M.P.H., Chief Medical Officer and <person>Jessica Breu</person>, Vice President Investor Relations and Communications at <span value="NASDAQ-NMS:IMUX" idsrc="xmltag.org" >Immunic</span>, will participate in one-on-one investor meetings at this conference in <location value="LU/us.ma.boston" idsrc="xmltag.org" >Boston</location>. To http://www.streetinsider.com/Press+Releases/Immunic+to+Participate+in+Investor+Conferences+in+July/26749711.html Thu, 09 Jul 2026 06:30:00 -0400 A.31492554 IMUX O.02321652 O.20507970 http://www.streetinsider.com/Press+Releases/Immunic+to+Participate+in+Investor+Conferences+in+July/26749711.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 9, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4727649-1&amp;h=3646705886&amp;u=https%3A%2F%2Fimux.com%2F&amp;a=Immunic%2C+Inc." target="_blank" rel="nofollow"><b><span value="NASDAQ-NMS:IMUX" idsrc="xmltag.org" >Immunic</span></b><b>, Inc.</b></a><b> (Nasdaq: IMUX)</b>, a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following investor conferences in July:</p><ul type="disc"><li><chron>July 14-15</chron>: <b><span>Leerink Partners Therapeutics Forum</span>.</b> Erik Lundgren, Chief Executive Officer, <person>Jason Tardio</person>, President and Chief Operating Officer, <person>Michael A. Panzara</person>, M.D., M.P.H., Chief Medical Officer and <person>Jessica Breu</person>, Vice President Investor Relations and Communications at <span value="NASDAQ-NMS:IMUX" idsrc="xmltag.org" >Immunic</span>, will participate in one-on-one investor meetings at this conference in <location value="LU/us.ma.boston" idsrc="xmltag.org" >Boston</location>. To http://www.streetinsider.com/Press+Releases/Immunic+to+Participate+in+Investor+Conferences+in+July/26749711.html Thu, 09 Jul 2026 06:30:00 -0400 A.31492554 IMUX O.02321652 O.20507970 http://www.streetinsider.com/Press+Releases/Immunic+to+Participate+in+Investor+Conferences+in+July/26749711.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 9, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4727649-1&amp;h=3646705886&amp;u=https%3A%2F%2Fimux.com%2F&amp;a=Immunic%2C+Inc." target="_blank" rel="nofollow"><b><span value="NASDAQ-NMS:IMUX" idsrc="xmltag.org" >Immunic</span></b><b>, Inc.</b></a><b> (Nasdaq: IMUX)</b>, a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following investor conferences in July:</p><ul type="disc"><li><chron>July 14-15</chron>: <b><span>Leerink Partners Therapeutics Forum</span>.</b> Erik Lundgren, Chief Executive Officer, <person>Jason Tardio</person>, President and Chief Operating Officer, <person>Michael A. Panzara</person>, M.D., M.P.H., Chief Medical Officer and <person>Jessica Breu</person>, Vice President Investor Relations and Communications at <span value="NASDAQ-NMS:IMUX" idsrc="xmltag.org" >Immunic</span>, will participate in one-on-one investor meetings at this conference in <location value="LU/us.ma.boston" idsrc="xmltag.org" >Boston</location>. To http://www.streetinsider.com/Press+Releases/Immunic+to+Participate+in+Investor+Conferences+in+July/26749711.html Thu, 09 Jul 2026 06:30:00 -0400 A.31492554 IMUX O.02321652 O.20507970 http://www.streetinsider.com/Press+Releases/Immunic+to+Participate+in+Investor+Conferences+in+July/26749711.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 9, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4727649-1&amp;h=3646705886&amp;u=https%3A%2F%2Fimux.com%2F&amp;a=Immunic%2C+Inc." target="_blank" rel="nofollow"><b><span value="NASDAQ-NMS:IMUX" idsrc="xmltag.org" >Immunic</span></b><b>, Inc.</b></a><b> (Nasdaq: IMUX)</b>, a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following investor conferences in July:</p><ul type="disc"><li><chron>July 14-15</chron>: <b><span>Leerink Partners Therapeutics Forum</span>.</b> Erik Lundgren, Chief Executive Officer, <person>Jason Tardio</person>, President and Chief Operating Officer, <person>Michael A. Panzara</person>, M.D., M.P.H., Chief Medical Officer and <person>Jessica Breu</person>, Vice President Investor Relations and Communications at <span value="NASDAQ-NMS:IMUX" idsrc="xmltag.org" >Immunic</span>, will participate in one-on-one investor meetings at this conference in <location value="LU/us.ma.boston" idsrc="xmltag.org" >Boston</location>. To http://www.streetinsider.com/Press+Releases/Immunic+to+Participate+in+Investor+Conferences+in+July/26749711.html Thu, 09 Jul 2026 06:30:00 -0400 A.31492554 IMUX O.02321652 O.20507970 http://www.streetinsider.com/PRNewswire/Immunic+to+Participate+in+Investor+Conferences+in+July/26749711.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 9, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4727649-1&amp;h=3646705886&amp;u=https%3A%2F%2Fimux.com%2F&amp;a=Immunic%2C+Inc." target="_blank" rel="nofollow"><b><span value="NASDAQ-NMS:IMUX" idsrc="xmltag.org" >Immunic</span></b><b>, Inc.</b></a><b> (Nasdaq: IMUX)</b>, a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following investor conferences in July:</p><ul type="disc"><li><chron>July 14-15</chron>: <b><span>Leerink Partners Therapeutics Forum</span>.</b> Erik Lundgren, Chief Executive Officer, <person>Jason Tardio</person>, President and Chief Operating Officer, <person>Michael A. Panzara</person>, M.D., M.P.H., Chief Medical Officer and <person>Jessica Breu</person>, Vice President Investor Relations and Communications at <span value="NASDAQ-NMS:IMUX" idsrc="xmltag.org" >Immunic</span>, will participate in one-on-one investor meetings at this conference in <location value="LU/us.ma.boston" idsrc="xmltag.org" >Boston</location>. To http://www.streetinsider.com/PRNewswire/Immunic+to+Participate+in+Investor+Conferences+in+July/26749711.html Thu, 09 Jul 2026 06:30:00 -0400 A.31492554 IMUX O.02321652 O.20507970 http://www.streetinsider.com/PRNewswire/Immunic+to+Participate+in+Investor+Conferences+in+July/26749711.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 9, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4727649-1&amp;h=3646705886&amp;u=https%3A%2F%2Fimux.com%2F&amp;a=Immunic%2C+Inc." target="_blank" rel="nofollow"><b><span value="NASDAQ-NMS:IMUX" idsrc="xmltag.org" >Immunic</span></b><b>, Inc.</b></a><b> (Nasdaq: IMUX)</b>, a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following investor conferences in July:</p><ul type="disc"><li><chron>July 14-15</chron>: <b><span>Leerink Partners Therapeutics Forum</span>.</b> Erik Lundgren, Chief Executive Officer, <person>Jason Tardio</person>, President and Chief Operating Officer, <person>Michael A. Panzara</person>, M.D., M.P.H., Chief Medical Officer and <person>Jessica Breu</person>, Vice President Investor Relations and Communications at <span value="NASDAQ-NMS:IMUX" idsrc="xmltag.org" >Immunic</span>, will participate in one-on-one investor meetings at this conference in <location value="LU/us.ma.boston" idsrc="xmltag.org" >Boston</location>. To http://www.streetinsider.com/PRNewswire/Immunic+to+Participate+in+Investor+Conferences+in+July/26749711.html Thu, 09 Jul 2026 06:30:00 -0400 A.31492554 IMUX O.02321652 O.20507970 http://www.streetinsider.com/PRNewswire/Immunic+to+Participate+in+Investor+Conferences+in+July/26749711.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 9, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4727649-1&amp;h=3646705886&amp;u=https%3A%2F%2Fimux.com%2F&amp;a=Immunic%2C+Inc." target="_blank" rel="nofollow"><b><span value="NASDAQ-NMS:IMUX" idsrc="xmltag.org" >Immunic</span></b><b>, Inc.</b></a><b> (Nasdaq: IMUX)</b>, a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following investor conferences in July:</p><ul type="disc"><li><chron>July 14-15</chron>: <b><span>Leerink Partners Therapeutics Forum</span>.</b> Erik Lundgren, Chief Executive Officer, <person>Jason Tardio</person>, President and Chief Operating Officer, <person>Michael A. Panzara</person>, M.D., M.P.H., Chief Medical Officer and <person>Jessica Breu</person>, Vice President Investor Relations and Communications at <span value="NASDAQ-NMS:IMUX" idsrc="xmltag.org" >Immunic</span>, will participate in one-on-one investor meetings at this conference in <location value="LU/us.ma.boston" idsrc="xmltag.org" >Boston</location>. To http://www.streetinsider.com/PRNewswire/Immunic+to+Participate+in+Investor+Conferences+in+July/26749711.html Thu, 09 Jul 2026 06:30:00 -0400 A.31492554 IMUX O.02321652 O.20507970 http://www.streetinsider.com/PRNewswire/Immunic+to+Participate+in+Investor+Conferences+in+July/26749711.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ny.nyc" idsrc="xmltag.org" >NEW YORK</location></span>, <span class="legendSpanClass"><chron>July 9, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4727649-1&amp;h=3646705886&amp;u=https%3A%2F%2Fimux.com%2F&amp;a=Immunic%2C+Inc." target="_blank" rel="nofollow"><b><span value="NASDAQ-NMS:IMUX" idsrc="xmltag.org" >Immunic</span></b><b>, Inc.</b></a><b> (Nasdaq: IMUX)</b>, a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following investor conferences in July:</p><ul type="disc"><li><chron>July 14-15</chron>: <b><span>Leerink Partners Therapeutics Forum</span>.</b> Erik Lundgren, Chief Executive Officer, <person>Jason Tardio</person>, President and Chief Operating Officer, <person>Michael A. Panzara</person>, M.D., M.P.H., Chief Medical Officer and <person>Jessica Breu</person>, Vice President Investor Relations and Communications at <span value="NASDAQ-NMS:IMUX" idsrc="xmltag.org" >Immunic</span>, will participate in one-on-one investor meetings at this conference in <location value="LU/us.ma.boston" idsrc="xmltag.org" >Boston</location>. To http://www.streetinsider.com/PRNewswire/Immunic+to+Participate+in+Investor+Conferences+in+July/26749711.html Thu, 09 Jul 2026 06:30:00 -0400 A.31492554 IMUX O.02321652 O.20507970 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+05++Filed+by%3A+Rudick+Richard+Alan/26741830.html si-local-file:///var/storage/secattach/20260707/26741830.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+05++Filed+by%3A+Rudick+Richard+Alan/26741830.html Tue, 07 Jul 2026 16:07:00 -0400 IMUX O.02321652 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+05++Filed+by%3A+Rudick+Richard+Alan/26741830.html si-local-file:///var/storage/secattach/20260707/26741830.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+05++Filed+by%3A+Rudick+Richard+Alan/26741830.html Tue, 07 Jul 2026 16:07:00 -0400 IMUX O.02321652 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+05++Filed+by%3A+Skerjanec+Simona/26741842.html si-local-file:///var/storage/secattach/20260707/26741842.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+05++Filed+by%3A+Skerjanec+Simona/26741842.html Tue, 07 Jul 2026 16:07:00 -0400 IMUX O.02321652 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+05++Filed+by%3A+Skerjanec+Simona/26741842.html si-local-file:///var/storage/secattach/20260707/26741842.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+05++Filed+by%3A+Skerjanec+Simona/26741842.html Tue, 07 Jul 2026 16:07:00 -0400 IMUX O.02321652 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+05++Filed+by%3A+Neermann+Joerg/26741806.html si-local-file:///var/storage/secattach/20260707/26741806.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+05++Filed+by%3A+Neermann+Joerg/26741806.html Tue, 07 Jul 2026 16:06:00 -0400 IMUX O.02321652 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+05++Filed+by%3A+Neermann+Joerg/26741806.html si-local-file:///var/storage/secattach/20260707/26741806.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+05++Filed+by%3A+Neermann+Joerg/26741806.html Tue, 07 Jul 2026 16:06:00 -0400 IMUX O.02321652 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+05++Filed+by%3A+PHILLIPS+BARCLAY+A/26741823.html si-local-file:///var/storage/secattach/20260707/26741823.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+05++Filed+by%3A+PHILLIPS+BARCLAY+A/26741823.html Tue, 07 Jul 2026 16:06:00 -0400 IMUX O.02321652 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+05++Filed+by%3A+PHILLIPS+BARCLAY+A/26741823.html si-local-file:///var/storage/secattach/20260707/26741823.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+05++Filed+by%3A+PHILLIPS+BARCLAY+A/26741823.html Tue, 07 Jul 2026 16:06:00 -0400 IMUX O.02321652 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+05++Filed+by%3A+Congleton+Jon/26741793.html si-local-file:///var/storage/secattach/20260707/26741793.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+05++Filed+by%3A+Congleton+Jon/26741793.html Tue, 07 Jul 2026 16:05:00 -0400 IMUX O.02321652 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+05++Filed+by%3A+Congleton+Jon/26741793.html si-local-file:///var/storage/secattach/20260707/26741793.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jul+05++Filed+by%3A+Congleton+Jon/26741793.html Tue, 07 Jul 2026 16:05:00 -0400 IMUX O.02321652 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jun+29/26735830.html si-local-file:///var/storage/secattach/20260706/26735830.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jun+29/26735830.html Mon, 06 Jul 2026 16:22:00 -0400 IMUX O.02321652 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jun+29/26735830.html si-local-file:///var/storage/secattach/20260706/26735830.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jun+29/26735830.html Mon, 06 Jul 2026 16:22:00 -0400 IMUX O.02321652 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jun+29++Filed+by%3A+Congleton+Jon/26706985.html si-local-file:///var/storage/secattach/20260629/26706985.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++IMMUNIC%2C+INC.+++++++++++++For%3A+Jun+29++Filed+by%3A+Congleton+Jon/26706985.html Mon, 29 Jun 2026 16:35:00 -0400 IMUX O.02321652